international magazine of oral implantology

I manufacturer _ news 44 I implants1_2011 Manufacturer News BEGO Implant Systems Mediterranean Implantology Symposium 2011 “Implantology— the complete state-of-the-art:from planning to final rehabili- tation”—thefirstBEGOMediterraneanSymposium—willtakeplaceon20and 21May2011.Besuretomakeanoteofthisdatenow.Thenumberofdelegates at this exclusive event will be restricted to 300. Onbothdays,delegateswillreceivean up-to-date overview of the im- plant issues affecting ambi- tious implantologists and which are currently be- ing discussed world- wide. The topics range from 3-D implant plan- ning and surgical naviga- tion to complicated aug- mentation techniques and CAD/CAM in implant prostho- dontics, to name but a few. 15 top-class international speakers will give interesting,in-depth explanations of the scientific background to the topics. The speakers from seven different countries(Spain,Turkey,Germany,theNetherlands)includeProfDrDrSchultze- Mosgau (Jena), Prof Dr Wainwright (Düsseldorf), Dr. Fernandez (Ibiza, Barcelona), Dr Abboud (Bonn), PD Dr Dr Rothamel (Cologne), Prof Dr Artunc (Izmir). The symposium will take place in the renowned 5-star Dolce Hotel (www.dolce.com) in Sitges (36 km south-west of Barcelona).In addition to the mentallyenrichingsymposium,delegateswithakeeninterestinsportcanpar- take in some physical exercise on the golf course adjacent to the hotel or in the large spa in Sitges.The delegate fee for the two-day symposium is €350, whichincludescateringduringthedayandacertificateofattendance. Thereisanadditionalchargeof€80fortheFridayeveningevent. You can save €60 if you register early,not later than the end of January 2011.The symposium will be conducted in English. BEGO Implant Systems GmbH & Co. KG Technologiepark Universität Wilhelm-Herbst-Straße 1 28359 Bremen, Germany wachendorf@bego.com www.bego.com Produits Dentaires A trend-setter bows out Nofalsemodesty,theconceptisbrilliant:abonefilling materialwhichisinjectable,hardeninginsitu,ready- to-use, fully synthetic, completely resorbable and fi- nally replaced by bone,all this without using a mem- brane.Themiracleproduct! PD (Produits Dentaires SA, Switzerland) started ten years ago the development for the dental industry of a brushite bone regeneration prod- uct stemming from the Swiss Fed- eral Institute of Technology in Lau- sanne.Fiveyearslater,in2006,theresult, PD VitalOs Cement, was launched on the market. During five years of commercializa- tion, we have convinced numerous users of the concept,especiallyamongthosebelievingthattheso- lutionspresentlyavailablearenotquitesatisfyingyet. However,aconceptchangeoftenimpliestorevisethe wayofthinkingandworking.Nowtheimpliedchange has not always been accepted and the number of users reached so far is not sufficient to achieve sales figures covering the costs.This is the reason why,to- day,PDdecidestostopmanufacturingVitalOs. So,wastheconceptnotthatbrilliant?Notatall,itwas andremainsbrilliant.Butitmaybethatitwastooam- bitious,orsimplyaheadofthetimes. What can we learn from such an experience? Obvi- ously, that the miracle product does not exist yet. On the other hand,it is certainly possible to find the ade- quateandperformingproductforeachclinicalindica- tionorsituation.ForVitalOs,theclinicalresultsareex- ceptional in specific situations in immediate implan- tation,aswellasforhorizontalridgedistraction.How- ever,the restricted indications also limit the revenue, andthelatterturnsouttobeinsufficient,atleastinthe model followed so far.VitalOs is a product that would most make sense inside a complete bone regenera- tionportfolio,witheachproductdedicatedtoaspe- cificindicationwhereitperformsbest. Wellthen?Whatwillhappenwiththeproduct? Maybe another manufacturer will show in- terest to integrate it into its product port- folio? It’s difficult to say this today. At least, the concept will leavetraces,somearealreadyvisibletoday,lookingat the increasing number of products presented in sy- ringes,ready-to-use,and even some with hardening properties. For the time being,we would like to thank warmly all thepartnersthattookpartintheproject,especiallythe userswhotookthetimetounderstandtheproductand to adapt their way of working in order to get the best possibleresults.Wealsowouldliketoaddressourvery special thanks to the opinion leaders who set up and ranthestudies,andpresentedtheirresultsinarticles orinpresentationsduringcongresses. PD focuses now strategically on its core business (www.pdsa.ch), and wishes that the users who adoptedtheproductwillfindinthefutureaproductis- suedfromtheconcepttheyhavestuckto. ChristianPittet,ProductManager MarcFehlmann,CEO Produits Dentaires SA Rue des Bosquets 18 1800 Vevey, Switzerland marc.fehlmann@pdsa.ch www.pdsa.ch